Company profile: Avalyn Pharma
1.1 - Company Overview
Company description
- Provider of inhaled therapies for idiopathic pulmonary fibrosis and other respiratory diseases, advancing direct-lung delivery candidates including AP01 (Phase 2b-ready inhaled pirfenidone), AP02 (reformulated inhaled nintedanib; Phase 1a completed), AP02-DP (dry powder nintedanib with equivalent pulmonary bioavailability), AP03 (fixed-dose inhaled pirfenidone+nintedanib), and AP04 (inhaled imatinib for PAH).
Products and services
- AP01 (Inhaled Pirfenidone): Phase 2b-ready inhaled formulation engineered to deliver pirfenidone directly to the lungs for treating pulmonary fibrosis, designed for direct lung delivery
- AP03 (Inhaled Fixed-Dose Combination of Pirfenidone & Nintedanib): Fixed-dose inhaled product combining pirfenidone and nintedanib to reduce adverse effects and improve efficacy, enabling simultaneous lung-directed delivery for pulmonary fibrosis
- AP02 (Inhaled Nintedanib): Reformulated inhaled nintedanib for pulmonary fibrosis treatment with a completed Phase 1a study, delivered as an inhaled version for pulmonary administration
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Avalyn Pharma
Twelve Bio
HQ: Denmark
Website
- Description: Provider of CRISPR-Cas12a-based diagnostic technology for detecting and editing DNA sequences, leveraging an RNA-protein molecule where RNA identifies specific DNA targets and the protein acts as a biological scissor to cut and modify them.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Twelve Bio company profile →
Spectral Genomics
HQ: United States
Website
- Description: Provider of innovative products for human genetics and Genomic Profiling(SM) services for academic and industrial research laboratories; a global supplier headquartered in Houston, TX.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Spectral Genomics company profile →
Covalon
HQ: Canada
Website
- Description: Provider of healthcare technologies for wound care and IV site protection, including CovaWound Foam non-adherent dressings, CovaWound Hydrocolloid Dressings for light exuding wounds, ColActive PLUS Ag collagen dressings with silver for antimicrobial protection, IV Clear transparent dressings to secure IV sites, and VALGuard to safeguard IV connections and reduce infection risk.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Covalon company profile →
Protea Biosciences
HQ: United States
Website
- Description: Provider of mass spectrometry standards and services, including mass spectrometry imaging via LAESI and MALDI, HGMS integrating optical microscopy and histology, and LC-MS for proteomics, metabolomics, and protein characterization, enabling direct ionization, high-resolution spatial mapping, and targeted chemical profiling across diverse sample types.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Protea Biosciences company profile →
Caliper Life Sciences
HQ: United States
Website
- Description: Provider of integrated systems consisting of instruments, software and reagents, laboratory automation tools, and assay and discovery services for pharmaceutical and biotechnology companies, and government and other not-for-profit research institutions worldwide.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Caliper Life Sciences company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Avalyn Pharma
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Avalyn Pharma
2.2 - Growth funds investing in similar companies to Avalyn Pharma
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Avalyn Pharma
4.2 - Public trading comparable groups for Avalyn Pharma
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →